The First Iran Plasma Conference An important point regarding this industry is that the supply of its raw materials depends on human beings. It is people who donate, and the human dimension in the plasma industry is highly significant and should receive more attention. The three key points needed for the development of this industry are: firstly, investors in this sector must be supported; secondly, the regulator should not be part of the blood transfusion organization, and therefore, the supervision of the Food and Drug Administration as the regulator must be precise and present. Thirdly, policies need to be sustainable, and shifting from one branch to another in policymaking will not benefit the country. We are in a golden period in the history of the plasma industry, and the world, facing shortages in plasma, is ready to invest in this sector. By developing the plasma industry, we will enter the phase of exporting plasma derived medicines in the future. However, the crucial point is that these drugs must be registered in target countries, which is a time consuming process, and we need to start thinking about it now. This conference, consisting of several speeches and two specialized panels, was held on Thursday, October 27, 2022, in the conference hall of Milad Tower.

Events